Program Schedule
Toggle navigation
Welcome
All sessions are noted in Eastern Time Zone. Please adjust to your time zone accordingly
Full Program
11/2/2021
11/3/2021
11/4/2021
11/5/2021
Tuesday
November 2, 2021
9:00 AM - 10:30 AM ET
100 - KEYNOTE ADDRESS: COVID-19: Pandemic to Endemic
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA;
Sophia Chu Rodgers, DNP, ACNP, FNP, FAANP, FCCM, Critical Care Nurse Practitioner, Lovelace Health Systems, Albuquerque, NM
×
100 - KEYNOTE ADDRESS: COVID-19: Pandemic to Endemic
CE Credit: 1.5; Rx Credit: 1
As the SARS Coronavirus-2 pandemic continues, our knowledge expands and evolves. In this presentation, find out more about the state of variant viruses, the impact of the outpatient and inpatient treatment, and how the pandemic has shifted to one of the unvaccinated and children. Advances and limitations of outpatient and inpatient therapy will be highlighted as well as updates on COVID-19 immunization. In addition, consideration for shifting from pandemic to endemic.
Learning Outcomes/Objectives:
Identify known and emerging therapies in the prevention and treatment of COVID-19 infection.
Discuss variant viruses.
Describe ways to attain global immunity.
10:45 AM - 12:00 PM ET
101 - Product Theater: Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
Debbie Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, Advanced Practice Nurse and Certified Diabetes Educator, Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, CO
Sponsored by Novo Nordisk
×
101 - Product Theater: Shifting Perspectives: How Do You Choose the Next Oral Therapy for T2D?
CE/Rx will not be offered for this sponsored event.
Review the pathophysiology of T2D and the recommendations from relevant associations on the oral treatment options that should be used after metformin in the T2D treatment plan. Discuss head-to-head data for a once-daily treatment option from pivotal glycemic control trials and safety data from a cardiovascular outcomes trial, followed by dosing and administration information.
12:00 PM - 1:00 PM ET
102 - Exhibitor Showcase/Lunch/Posters
×
102 - Exhibitor Showcase/Lunch/Posters
CE Credit: 1; Rx Credit: 0
Check out the Exhibitor Showcase and Posters during this time.
1:00 PM - 2:30 PM ET
103 - Non-Pharmacologic Management of Pain
Amy Siple, FNP, President for the Kansas Advanced Practice Nurses Association, Independent Geriatric Nurse Practitioner, Wichita, KS
×
103 - Non-Pharmacologic Management of Pain
CE Credit: 1.5; Rx Credit: 0
This program explores the etiology of pain and why we respond so differently to painful stimuli. Types of pain will be discussed and the role of non-pharmacologic strategies for pain management will be addressed.
Learning Outcomes/Objectives:
Identify the purpose of pain.
Recall at least two pain assessment tools.
Report at least two reasons why there are varied response to noxious stimuli.
Identify at least two non-pharmacologic management strategies to control pain
1:00 PM - 2:30 PM ET
104 - Up and Down the GI Track: What’s New?
Peter Buch, MD, FACG, AGAF, FACP, Associate Clinical Professor of Medicine, University of Connecticut School of Medicine, ECHN Branch of the University of New England College of Osteopathic Medicine
Frank H Netter, MD School of Medicine, Haven, CT
×
104 - Up and Down the GI Track: What’s New?
CE Credit: 1.5; Rx Credit: 1
The practice of gastroenterology is always changing. What is the best treatment for eosinophilic esophagitis? Why is non-alcoholic fatty liver disease important? How does a fecal immunochemical test or a fecal DNA test compare with a screening colonoscopy? Join Dr. Peter Buch as he answers these questions and many more in a case-based format that will provide you with the latest clinical tools in gastroenterology.
Learning Outcomes/Objectives:
Identify the various treatments for eosinophilic esophagitis.
Define non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
List treatment options for each.
Describe the workup of celiac disease in a patient who is on a self-imposed gluten free diet.
Identify the "best" way to diagnose Clostridioides difficile.
Identify the therapeutic options for Clostridioides difficile.
1:00 PM - 2:30 PM ET
105 - Acute/Urgent/Emergency Care: Managing Alcohol Withdrawal Syndrome in Acute Care
Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN, Critical Care NP, Penn Medicine, Chester County Hospital, West Chester, PA; Adjunct Faculty, Drexel University, Philadelphia, PA; Chief Nurse, Wolters Kluwer; Health, Learning, Research & Practice, Philadelphia, PA
×
105 - Acute/Urgent/Emergency Care: Managing Alcohol Withdrawal Syndrome in Acute Care
CE Credit: 1.5; Rx Credit: 1.5
Alcohol abuse is a prevalent issue and often the extent of the problem is not visible until the patient is hospitalized with another diagnosis and begins experiencing alcohol withdrawal symptoms. This session will review the etiology, presentation, diagnosis, and several management strategies for managing symptoms and complications of alcohol withdrawal.
Learning Outcomes/Objectives:
Identify the etiology and pathophysiology of alcohol withdrawal syndrome (AWS).
Identify methods to screen patients at risk for AWS and identify appropriate diagnostic studies to monitor for complications.
Identify management strategies for AWS symptoms using pharmacologic and non-pharmacologic therapies.
2:30 PM - 3:30 PM ET
106 - Exhibitor Showcase/Posters
Check out the Exhibitor Showcase and Posters during this time.
3:30 PM - 5:00 PM ET
107 - Expert Tips to Managing Adrenal Disorders in Primary and Acute Care
Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP, Founder, Metabolic Medicine Associates, King George, VA
×
107 - Expert Tips to Managing Adrenal Disorders in Primary and Acute Care
CE Credit: 1.5; Rx Credit: 1.5
Considered exotic by some, intimidating to many, and often misunderstood by acute and primary care providers, adrenal disorders are common, ubiquitous findings that cause and exacerbate physiological upheaval. This session will provide attendees with endocrinology tips to help better identify, diagnose, and treat adrenal insufficiency, Cushing’s syndrome, adrenal incidentaloma, and “adrenal fatigue.”
Learning Outcomes/Objectives:
Analyze clinical presentation, work-up, and preliminary treatment for chronic and acute adrenal cortical insufficiency, Cushing’s syndrome, and the incidental finding of an adrenal adenoma.
Discuss the facts and fallacies surrounding the concept of “adrenal fatigue.”
Discuss proper follow-up and referral for selected adrenal disorders.
3:30 PM - 5:00 PM ET
108 - The Choosing Wisely Campaign: Top 10 Medications to Avoid in the Geriatric Patient
Steven Atkinson, PA-C, MS, Founder and Co-Owner/Adjunct Faculty/Owner, Twin Cities Physicians, Inc. University of Utah School of Medicine/Mindful Geriatrics, LLC
×
108 - The Choosing Wisely Campaign: Top 10 Medications to Avoid in the Geriatric Patient
CE Credit: 1.5; Rx Credit: 1.5
Explore medication dosing guidelines and polypharmacy management principles to ensure safe prescribing in the geriatric patient. Review the top 10 medications to avoid and alternatives that can be equally effective.
Learning Outcomes/Objectives:
Apply age-sensitive principles for medication dosing and management to clinical scenarios.
Analyze key questions useful for identifying and managing polypharmacy in older adults.
3:30 PM - 5:00 PM ET
109 - Acute/Urgent/Emergency Care: Sepsis: What’s New in the Definition and Treatment?
Sophia Chu Rodgers, DNP, ACNP, FNP, FAANP, FCCM, Critical Care Nurse Practitioner, Lovelace Health Systems, Albuquerque, NM
×
109 - Acute/Urgent/Emergency Care: Sepsis: What’s New in the Definition and Treatment?
CE Credit: 1.5; Rx Credit: 1
Sepsis is the leading cause of death in the noncoronary ICU with mortality approaching 30% to 50%. Using a case-based scenario, this presentation will discuss the epidemiology, pathophysiology, and etiology of this deadly condition. Moreover, it will also review the Third Consensus definition of sepsis and septic shock while reviewing the latest evidence-based treatment guidelines.
Learning Outcomes/Objectives:
Discuss the epidemiology and pathophysiology of sepsis.
Define sepsis and septic shock using the Third Consensus definitions.
Describe the latest evidenced-based treatment for the treatment of sepsis.
Wednesday
November 3, 2021
8:30 AM - 10:00 AM ET
200 - GENERAL SESSION: Diversity, Equity, and Belonging
Sheldon D. Fields, PhD, RN, CRNP, FNP-BC, AACRN, FAANP, FNAP, FAAN, Associate Dean for Equity and Inclusion, Research Professor, Ross and Carol Nese College of Nursing, The Pennsylvania State University, RWJF Health Policy Fellow, Alumni, First Vice President, National Black Nurses Association, Inc.
×
200 - GENERAL SESSION: Diversity, Equity, and Belonging
CE Credit: 1.5; Rx Credit: 0
In this session, we’ll seek the discovery of diversity, equity and belonging as it relates to patient care, perceptions, overall experience, and health outcomes.
Learning Outcomes/Objectives:
Define personal racial, ethnic, and cultural identity.
Identify best practices for diversity, equity, and inclusion in the healthcare arena.
10:00 AM - 11:00 AM ET
201 - Exhibitor Showcase/Posters
Check out the Exhibitor Showcase and Poster Sessions during this time.
11:00 AM - 12:30 PM ET
202 - Anxiously Awaited: Update on Neurobiology & Personalized Treatment ofAnxiety Disorders
Josh Hamilton, DNP, RN-BC, FNP-C, PMHNP-BC, CTMH, CNE, FAANP; Chief Clinical Officer, The Hamilton Group Behavioral Health, Las Vegas, NV
×
202 - Anxiously Awaited: Update on Neurobiology & Personalized Treatment ofAnxiety Disorders
CE Credit: 1.5; Rx Credit: 1.5
In this presentation, updated diagnostic criteria and disease models for anxiety disorders are reviewed. Neurobiological and epigenetic mechanisms that underlie anxiety symptoms are presented as the basis for therapeutic interventions. Specific attention is given to the formulation of rational, genomically informed pharmacologic treatment approaches for anxiety disorders. Practical applications for nurse practitioners are presented.
Learning Outcomes/Objectives:
Develop a working knowledge of updated diagnostic criteria and disease models to improve case identification and diagnosis of anxiety disorders.
Discuss contemporary approaches to management of anxiety disorders, including practical applications for nurse practitioners.
Explore evidence- and eminence-based approaches, including pharmacogenomics, to selecting and monitoring treatments for anxiety.
11:00 AM - 12:30 PM ET
203 - GERD: Should I Discontinue My Patient’s Proton Pump Inhibitor?
Monica Nandwani, DNP, RN, FNP-BC, Manager of Advanced Practice Providers and Gastroenterology Nurse Practitioner, Stanford Healthcare, Stanford, CA
×
203 - GERD: Should I Discontinue My Patient’s Proton Pump Inhibitor?
CE Credit: 1.5; Rx Credit: 1.5
Gastroesophageal reflux disease (GERD) is a common condition with an estimated 1 in 5 Americans experiencing at least once weekly symptoms of GERD. As GERD is a commonly encountered disease with various clinical manifestations, it is managed by clinicians across specialties and is a frequent indication for gastroenterology referral. Proton pump inhibitors (PPIs) are one of the mainstays of GERD management and this presentation will provide an overview of PPI therapy and discuss discontinuation when appropriate. Additionally, this lecture will review phenotypes of GERD, differential diagnoses to consider, diagnostic testing, and therapeutic options.
Learning Outcomes/Objectives:
Identify typical and atypical symptoms of GERD and distinguish between proven and unproven GERD.
Describe strategies to optimize PPI therapy for the treatment of GERD and understand when to appropriately decrease or discontinue PPI therapy.
Summarize other management options for GERD.
11:00 AM - 12:30 PM ET
204 - Acute/Urgent/Emergency Care: Delivering Difficult News: What NPs Need to Know
Debbie A. Gunter APRN, FNP-BC, ACHPN, Family and Palliative Care Nurse Practitioner, Emory Healthcare, Atlanta, GA
×
204 - Acute/Urgent/Emergency Care: Delivering Difficult News: What NPs Need to Know
CE Credit: 1.5; Rx Credit: 0
Delivering difficult news to patients is a common occurrence for nurse practitioners. This sensitive task requires patience, refined communication skills, and must be approached with empathy for all parties involved. Many NPs view breaking difficult news as a communication skill that is only important for those working in end-of-life care, where the news can be that treatment has been unsuccessful or that death is imminent. However, all healthcare providers break difficult or life-changing news on different levels with all types of patient populations. The impact on patients and families can be devastating if this is handled poorly.
Learning Outcomes/Objectives:
Discuss the value of effective training in delivering difficult news to patients and families.
Outline the 6 step SPIKES protocol and how this could be utilized in the clinical setting.
Through case studies, implement the protocol for a variety of clinical scenarios.
12:30 PM - 1:30 PM ET
205 - Product Theater: Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE
Diane Wirth, ANP, CACP
Supported by Janssen Pharmaceuticals
×
205 - Product Theater: Clinical Insights in VTE: Treatment and Reduction in the Risk of Recurrent DVT/PE
CE/Rx will not be offered for this sponsored event.
This lecture will discuss the Treatment and Reduction in the Risk of Recurrent DVT/PE, whether initiated in the inpatient or outpatient setting.
1:30 PM - 2:30 PM ET
206 - Exhibitor Showcase and Poster Sessions
Check out the Exhibitor Showcase and Poster Sessions during this time.
2:30 PM - 4:00 PM ET
207 - Expanding the Rainbow: Understanding the Needs of the LGBTQIA+ patient
Vanessa Pomarico-Denino, EdD, FNP-BC, FAANP, Family Nurse Practitioner, Northeast Medical Group, Hamden, CT
×
207 - Expanding the Rainbow: Understanding the Needs of the LGBTQIA+ patient
CE Credit: 1.5; Rx Credit: 0.5
The LGBTQIA+ population has evolved over the past several years to include other gender non-conforming and gender minority populations. The individual needs of each population within this acronym vary and as a result need to have specialized, focused care to meet their healthcare needs. These gender and sexual minorities still encounter issues concerning sexuality, identity, gender, and freedom of expression with their healthcare providers. It is well-documented that most healthcare providers today have not been properly educated on how to care for this population, therefore, the specific needs pertaining to each individual group represented in this acronym go largely ignored. This session will focus on how to approach the care of the LGBTQIA+ patient and address their specific needs to promote patient-centered care
Learning Outcomes/Objectives:
Describe the appropriate language used when caring for the diverse and sexual minority patient populations.
Explain the differences between the populations within the LGBTQIA+ acronym.
Create appropriate, affirming, and welcoming patient intake forms.
Provide appropriate care to the individual populations within the LGBTQIA+ acronym.
2:30 PM - 4:00 PM ET
208 - The ABCs of CKD
Kim Zuber, PAC, Executive Director, American Academy of Nephrology Pas, St. Petersburg, FL
×
208 - The ABCs of CKD
CE Credit: 1.5; Rx Credit: 1.5
With the introduction of new CKD staging (without the race modifier), new diabetes management guidelines, new hypertension guidelines and new medications for the kidney patient, CKD diagnosis and management has been updated for the 21st century. One in 3 of your patients is at risk for CKD; do you know who they are? Come to The ABCs of CKD to learn how to identify and manage CKD in the 21st century!
Learning Outcomes/Objectives:
Review the pathophysiology of both the kidney and CKD to include the diagnosis of stages 1-5.
Discuss both the causes and treatments of CKD.
Discuss proven methods to prevent progression of CKD in patients.
2:30 PM - 4:00 PM ET
209 - Acute/Urgent/Emergency Care: Evaluation and Management of Back Pain
Tracey Anderson, MSN, CNRN, FNP-BC, ACNP-BC, Nurse Practitioner, Temecula Valley Neurosurgery, Murrieta, CA
×
209 - Acute/Urgent/Emergency Care: Evaluation and Management of Back Pain
CE Credit: 1.5; Rx Credit: 1
Back pain is one of the most frequent chief complaints seen in both the clinic and hospital setting. Guidelines released in the past 5 years are intended to help guide work up and reduce risk for ongoing narcotic dependence. We’ll review the work-up of back pain, treatment guidelines for non-surgical management, and discuss when it’s appropriate to escalate care after failure of medical management.
Learning Outcomes/Objectives:
Discuss back pain etiologies, including musculoskeletal injury and spinal column concerns.
Review current guidelines and management strategies for acute and chronic back pain.
Differentiate red flag symptoms necessitating further work up and referral.
4:00 PM - 5:00 PM ET
210 - Exhibit Showcase and Posters
Check out the Exhibitor Showcase and Poster Session during this time.
5:00 PM - 6:30 PM ET
211 - Pharmacologic Management of Patients with Lower Urinary Tract & Bowel Elimination Dysfunction
Mikel Gray, PhD, PNP, FNP, CUNP CCCN, FAANP, FAAN, Department of Urology, University of Virginia, Charlottesville, VA
×
211 - Pharmacologic Management of Patients with Lower Urinary Tract & Bowel Elimination Dysfunction
CE Credit: 1.5; Rx Credit: 1.5
Urinary incontinence drugs will also be discussed, mainly focusing on overactive bladder, drugs for urinary retention, drugs for management of erectile dysfunction, and interstitial cystitis/painful bladder syndrome. This session will also include a brief overview of urinary tract infection management.
Learning Outcomes/Objectives:
Define urinary tract infection, its epidemiology and pathophysiology.
Outline prevention strategies, focusing on underlying evidence and investigational techniques.
Discuss evaluation of domiciliary and healthcare acquired UTI.
Review management of UTI including pharmacologic and behavioral interventions.
5:00 PM - 6:30 PM ET
212 - Updates to Documentation, Billing, and Coding Services
Julia L Rogers, DNP, RN, CNS, FNP-BC, Assistant Professor, Purdue University Northwest, Hammond, IN; Nurse Practitioner, Northwest Medical Group Pulmonary and Critical Care Medicine, Valparaiso, IN
×
212 - Updates to Documentation, Billing, and Coding Services
CE Credit: 1.5; Rx Credit: 0
The new 2021 documentation requirements for CPT Evaluation and Management codes will be discussed during this session including revisions to COVID-19 coding guidelines. The extent of documentation needed within the history and exam based on the patient’s medical condition will be addressed, as well as how the provider can determine the level of service based on either time or medical decision.
Learning Outcomes/Objectives:
Identify the elements required in the history and exam documentation according to 2021 guidelines.
Determine the level of service billable based on time or medical decision-making.
Apply ethical coding and billing to practice cases.
5:00 PM - 6:30 PM ET
213 - Acute Glycemic Disorders
Eric Magana, MD, Internist, Presbyterian Hospital, Albuquerque, NM
×
213 - Acute Glycemic Disorders
CE Credit: 1.5; Rx Credit: 1.5
In this case-based session, we’ll cover the diagnosis of gap and non-gap metabolic acidosis, metabolic alkalosis, and acute and chronic respiratory acidosis and alkalosis. We’ll also discuss an approach to diagnosing the primary disturbance, limits of compensation, and the delta gap.
Learning Outcomes/Objectives:
Provide an approach to determine complex acid-base disorders.
Discuss the approach to determine primary disturbances, compensation, Anion gap and Delta gap.
Thursday
November 4, 2021
8:30 AM - 10:00 AM ET
300 - New Drug Update 2021: What’s Hot and What’s Not
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Adult/Family Nurse Practitioner, Wright & Associates Family Healthcare, Amherst, NH
×
300 - New Drug Update 2021: What’s Hot and What’s Not
CE Credit: 1.5; Rx Credit: 1.5
Keeping up with new medications, particularly given the plethora of direct-to-consumer advertising, is one of the true challenges of primary care. Ms. Wright will focus on the top new, widely used medications, including their appropriate uses, adverse effects, and drug interactions.
Learning Outcomes/Objectives:
Identify 10 – 20 new medications.
Discuss the use, side effects, drug-drug interactions, and benefits of each of the medications.
10:00 AM - 10:30 AM ET
301 - Exhibitor Showcase and Poster Sessions
Check out the Exhibitor Showcase and Poster Sessions during this time.
10:30 AM - 12:00 PM ET
302 - When What's on your Plate Makes you Ill: Food Allergy and Intolerance Deciphered
Ellen Karlin, MMSc, RDN, LDN, FADA, Nutrition Consultant, Private Practice
×
302 - When What's on your Plate Makes you Ill: Food Allergy and Intolerance Deciphered
CE Credit: 1.5; Rx Credit: 0
Food allergies and intolerances are growing and becoming serious public health concerns requiring significantly increased attention from nurse practitioners. This course will cover the nutritional management of food allergy, Celiac Disease, and irritable bowel syndrome. In addition, this session includes practical advice that you can share with your patients for food allergy prevention; based on the most recent guidance from the Dietary Guidelines for Americans, the American Academy of Allergy, Asthma, and Immunology and the American College of Allergy, Asthma, and Immunology.
Learning Outcomes/Objectives:
Identify the symptoms associated with food allergy, intolerance, and irritable bowel syndrome.
Delineate the challenges addressing the nutritional needs of the food allergy community.
Describe the paradigm shift in infant feeding guidelines for food allergy prevention.
10:30 AM - 12:00 PM ET
303 - Acneiform Skin Eruptions
Margaret Bobonich, DNP, FNP-C, DCNP, FAANP, Assistant Professor, Case Western Reserve University, School of Medicine and Frances Payne Bolton School of Nursing, University Hospitals Case Medical Center, Department of Dermatology, Cleveland, OH
×
303 - Acneiform Skin Eruptions
CE Credit: 1.5; Rx Credit: 1.5
We’ll discuss the most common acneiform skin eruptions in this presentation including acne (and beyond), rosacea seborrheic dermatitis, folliculitis, and perioral dermatitis.
Learning Outcomes/Objectives:
Review key morphology for acneiform eruptions.
Discuss distinguishing characteristic for differential diagnoses of acneiform skin eruptions.
Discuss important concepts in selecting appropriate pharmacotherapy for acnieform dermatoses.
10:30 AM - 12:00 PM ET
304 - Acute/Urgent/Emergency Care: Managing Non-Diabetes Endocrine Emergencies
Christine Kessler, MN, ANP-BC, CNS, BC-ADM, FAANP, Founder, Metabolic Medicine Associates, King George, VA
×
304 - Acute/Urgent/Emergency Care: Managing Non-Diabetes Endocrine Emergencies
CE Credit: 1.5; Rx Credit: 1.5
They are common, confusing, and often mimic other disorders—but can quickly evolve into a medical emergency, i.e.: acute endocrinopathies. A delay in treatment aimed at the precise hormonal disorder is almost always lethal. Using real acute care case studies, this lively session will provide attendees with expert endocrinology tips on how to effectively identify, evaluate, and provide urgent interventions for selected non-diabetic endocrine emergencies, such as thyroid storm, myxedema coma, acute hypopituitarism, and hypercalcemia.
Learning Outcomes/Objectives:
Identify risk factors that contribute to the development of thyroid, pituitary & hypercalcemic emergencies.
Discuss clinical and laboratory assessment findings in selected thyroid, pituitary & hypercalcemic emergencies.
Discuss treatment priorities for selected thyroid, pituitary & hypercalcemic emergencies.
12:00 PM - 1:30 PM ET
305 - Exhibitor Showcase and Posters
CE/Rx will not be offered for this sponsored event.
1:30 PM - 3:00 PM ET
306 - Laboratory Diagnosis: Challenging Cases
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA
×
306 - Laboratory Diagnosis: Challenging Cases
CE Credit: 1.5; Rx Credit: 1
Laboratory testing often plays a key role in formulating and/or refining the differential diagnosis. Dr. Margaret Fitzgerald presents challenging cases to help you refine your expertise in ordering laboratory tests and analyzing the results. Lab data discussed in this course include hepatic enzymes and hematologic and renal parameters.
Learning Outcomes/Objectives:
Discuss formulating and refining differential diagnosis.
Refine expertise in ordering laboratory tests.
1:30 PM - 3:00 PM ET
307 - Update on Osteoporosis and Fracture Prevention in Women and Men
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP, Adult Nurse Practitioner, Millennium Affiliated Physicians, Division of Michigan Healthcare Professionals, Farmington Hills, MI
×
307 - Update on Osteoporosis and Fracture Prevention in Women and Men
CE Credit: 1.5; Rx Credit: 1
This session will provide information regarding the identification of women and men at risk for fracture based on bone densitometry and their 10-year fracture risk using the FRAX calculation. Pharmacologic therapies will be reviewed including patient selection for first line therapies and therapies for patients at extremely high risk and drug risks and benefits. Current controversies will be discussed including long-term use of bisphosphonates, adverse events including osteonecrosis of the jaw (ONJ) and atypical subtrochanteric femur fractures and drug holidays. Concerns about discontinuation of rank ligand inhibitors and the rapid increase in vertebral fractures will be discussed. Treatment of patients at high risk due to therapy such as aromatase inhibitors and androgen deprivation therapy will be presented. Case studies will be used to provide real clinical scenarios.
Learning Outcomes/Objectives:
Discuss the diagnosis of osteoporosis, low bone mass and high risk for fracture.
Discuss current pharmacologic options for fracture prevention including bisphosphonates, rank ligand inhibitors, anabolic agents and an anti-sclerostin agent.
Discuss appropriate clinical management with case studies.
1:30 PM - 3:00 PM ET
308 - Acute/Emergency Care: Marijuana and its Cardiac Implications
Andrea Efre, DNP, ARNP, ANP-BC, Healthcare Education Consultants, Tampa, FL
×
308 - Acute/Emergency Care: Marijuana and its Cardiac Implications
CE Credit: 1.5; Rx Credit: 1.5
Marijuana has been used by many cultures for centuries, yet there is still much to be learned about its therapeutic uses and adverse effects. The lack of phase III clinical trials has prevented the medical community from understanding the efficacy, effectiveness, and safety of marijuana as a medication. Yet the legalization of recreational marijuana in various states has forced healthcare to consider the complex effects of marijuana on the body. This talk will provide an overview of marijuana use (both medical and recreational) and focus on its cardiac implications.
Learning Outcomes/Objectives:
Discuss the therapeutic and recreational uses of marijuana.
Define the action of cannabinoids, specifically the two main cannabinoids: tetrahydrocannabinol (THC) and cannabidiol (CBD).
Discuss appropriate clinical management with case studies.
Identify the effects and adverse effects of marijuana on the cardiovascular system.
3:00 PM - 3:30 PM ET
309 - Exhibit Showcase and Poster Session
Check out the Exhibitor Showcase and Posters during this time.
3:30 PM - 5:00 PM ET
310 - Latest in Treatment Options for Vaping and Tobacco Use: Successful Methods for Teens and Adults
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP, Adult/Family Nurse Practitioner, Wright & Associates Family Healthcare, Amherst, NH
×
310 - Latest in Treatment Options for Vaping and Tobacco Use: Successful Methods for Teens and Adults
CE Credit: 1.5; Rx Credit: 1.5
Approximately 13.7% of adults in the United States smoke cigarettes with another 27.5% of all teens having vaped or used an E-cig in the past 30 days. Vaping and tobacco use are associated with significant morbidity and mortality. It is essential that APRNs assess smoking status every visit and counsel patients about the importance of cessation. Strategies for successful vaping and tobacco use cessation practices in primary and specialty care will be discussed.
Learning Outcomes/Objectives:
Discuss statistics regarding cigarette, tobacco, and vaping.
Identify strategies to assist the individual with quitting smoking, vaping, tobacco use.
Review benefits and risks of the various pharmacologic practices.
3:30 PM - 5:00 PM ET
311 - Beyond LDL-C Lowering: Safety and Tolerability of Statin Therapy
Joyce L. Ross, MSN, CRNP, CS, FNLA, FPCNA, Diplomate Accreditation Council for Clinical Lipidology, Consultative Education Specialist, Cardiovascular Risk Intervention, Clinical Associate University of Pennsylvania Health System, Philadelphia, PA
×
311 - Beyond LDL-C Lowering: Safety and Tolerability of Statin Therapy
CE Credit: 1.5; Rx Credit: 1.5
Statin therapy is the medication of choice in the treatment of dyslipidemia. Many questions arise regarding the best statin for an individual patient, especially those related to cognition, influences with diabetes, statin intolerance, liver and muscle toxicity, and potential interactions with other medications. This session will address those issues separating myth from reality when it comes to these potential problems. Case studies will be presented related to guidelines and best practices.
Learning Outcomes/Objectives:
Understand that statin therapy is the mainstay for intervention in the management of dyslipidemia.
Recall effects and myths of statin therapy regarding cognition, diabetes, liver, muscle tolerability, and interactions with other drugs.
Individualize statin therapy based on safety and tolerability considerations.
3:30 PM - 5:00 PM ET
312 - Acute/Urgent/Emergency Care: Bugs vs Drugs: Gotta Kill Them All
Jonathan Van Cleve, PharmD, BCCCP, Critical Care Clinical Pharmacist, Lovelace Medical Center, Albuquerque, NM
×
312 - Acute/Urgent/Emergency Care: Bugs vs Drugs: Gotta Kill Them All
CE Credit: 1.5; Rx Credit: 1.5
Itchy nights, growing warts, blistering acne, balding scalps, crusty growths, and even bugs on and under the skin can create headaches and stress for parents, providers, and the children that come for help. Additionally, the presentations are not always textbook perfect: What are the differentials to a reddish round patch? Is yellow crusting always impetigo? Are there danger signs we should be aware of? This fast-paced presentation will include many photos and illustrations to help our primary care providers improve their assessment and treatment skills.
Learning Outcomes/Objectives:
Discuss differential diagnosis of common dermatologic conditions.
Identify danger signs.
Improve assessment skills and treatment regimes.
Friday
November 5, 2021
8:30 AM - 9:45 AM ET
400 - Getting Ready for the NP Boards
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA
×
400 - Getting Ready for the NP Boards
CE Credit: 1.5; Rx Credit: 0
Are you getting ready for the NP Certification Exam? NP Certification Expert Dr. Margaret A. Fitzgerald offers her insight and answers your questions.
Learning Outcomes/Objectives:
Learn how the exams compare and find out about recent changes from the AANP and ANCC.
Discover the best practices for preparing for certification.
Find out what to expect on the exams.
10:00 AM - 11:30 AM ET
401 - Good Grief - Instilling Hope and Empowering Patients to Overcome Loss
Jason Gleason, MS, FNP-C, USAF Lt Col (RET), Family Nurse Practitioner, Montana VA Health Clinic, Great Falls, MT
×
401 - Good Grief - Instilling Hope and Empowering Patients to Overcome Loss
CE Credit: 1.5; Rx Credit: 0
Loss runs so deep that it’s something one rarely gets over, but they can get through it! This interactive, innovative, and compelling session will take attendees on an incredible, heart-warming, knowledge- building journey through bereavement and how NPs can utilize psychosocial and pharmacological modalities to instill hope and empower patients to overcome their greatest loss.
Learning Outcomes/Objectives:
Identify grief-related terms, stages of grief, the incidence and impact of grief and bereavement.
Consider screening tools used for depression and anxiety.
Synthesize psychosocial coaching and counseling modalities and resources NPs in Primary Care can utilize to assist patients through the bereavement journey.
Describe pharmacological options for treating grief related depression and anxiety.
10:00 AM - 11:30 AM ET
402 - Pediatric Dermatology: The Challenges and Treatment Paradigms of Our Youngest Clients
Victor Czerkasij, MA, MSN, FNP-C, Skin Cancer and Cosmetic Dermatology, PC, Cleveland and Chattanooga, TN
×
402 - Pediatric Dermatology: The Challenges and Treatment Paradigms of Our Youngest Clients
CE Credit: 1.5; Rx Credit: 1.5
Itchy nights, growing warts, blistering acne, balding scalps, crusty growths, and even bugs on and under the skin can create headaches and stress for parents, providers, and the children that come for help. Additionally, the presentations are not always textbook perfect: What are the differentials to a reddish round patch? Is yellow crusting always impetigo? Are there danger signs we should be aware of? This fast-paced presentation will include many photos and illustrations to help our primary care providers improve their assessment and treatment skills.
Learning Outcomes/Objectives:
Discuss differential diagnosis of common dermatologic conditions.
Identify danger signs.
Improve assessment skills and treatment regimes.
10:00 AM - 11:30 AM ET
403 - Acute/Urgent/Emergency Care: Pain in the Acute Care Setting
Theresa Mallick-Searle, MS, RN-BC, ANP-BC, Adult Nurse Practitioner, Stanford Healthcare, Division of Pain Medicine, Redwood City, CA
×
403 - Acute/Urgent/Emergency Care: Pain in the Acute Care Setting
CE Credit: 1.5; Rx Credit: 1.5
Millions of patients each year suffer from acute pain because of trauma or illness.? Pain is the most common reason for admission to the emergency department (ED). The prevalence of acute pain is similarly high among patients undergoing surgery. In the United States, over 73 million surgical procedures are performed annually, and most patients report a high degree of poorly managed post-operative pain. Studies indicate that treatment of acute pain remains suboptimal due to attitudes and educational barriers on the part of clinicians and patients. The opioid crisis, insurance restrictions, and the release of the Joint Commission updated 2018 pain assessment and management standards, makes it more important than ever to adjust the way acute pain is managed. This presentation will review the differences between acute and chronic or persistent pain, while providing the audience with a multimodal treatment approach for the acute care setting.
Learning Outcomes/Objectives:
Discuss importance and challenges of managing pain in the acute care setting.
Explain the treatment options unique to the acute care setting.
Evaluate the use of pharmaceuticals and multimodal analgesia.
11:30 AM - 12:30 PM ET
404 - Break/View Posters
12:30 PM - 2:00 PM ET
405 - Hypertension Management Challenges: The Latest Treatment Options
Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP, Founder/Family NP, Fitzgerald Health Education Associates, LLC, Greater Lawrence Family Health Center, Lawrence, MA
×
405 - Hypertension Management Challenges: The Latest Treatment Options
CE Credit: 1.5; Rx Credit: 1.5
Hypertension is a complex disease that can result in target organ damage when untreated or poorly controlled. Dr. Fitzgerald will help you learn how to diagnose and choose the best treatment option for patients with difficult to control hypertension and special considerations in chronic kidney disease.
Learning Outcomes/Objectives:
Identify the use of select antihypertensive medications in patients with particularly difficult to control hypertension.
Define hypertensive urgency and hypertensive emergency.
Describe the appropriate plan of care for a person who presents with hypertensive urgency or hypertensive emergency.
12:30 PM - 2:00 PM ET
406 - Obesity: Why are we Losing the War?
Bruce D. Askey, ANP-BC, Sayre Weight Loss Center, Sayre, PA
×
406 - Obesity: Why are we Losing the War?
CE Credit: 1.5; Rx Credit: 0.5
Obesity has long since reached epidemic levels in the United States and is blossoming in developing countries. It has been classified as a chronic disease for several years. As many chronic diseases are caused or worsened by the presence of obesity, taking obesity out of the mix would go a long way toward improving the health of our world. This session provides an understanding of why obesity is so prevalent and gives the participant practical diet and exercise information that they can use in their clinic.
Learning Outcomes/Objectives:
Verbalize the appropriate macronutrient composition for a weight reduction diet.
Explain the pathophysiology of insulin resistance as it relates to weight gain.
Understand the role of weight reduction medications. .
12:30 PM - 2:00 PM ET
407 - Acute/Urgent/Emergency Care: OSA and Obesity Hypoventilation Syndrome in the ICU and Beyond: Are We Sleepwalking into Disaster?
Daria C. Ruffolo, DNP, RN, ACNP-BC, CCRN, Assistant Professor-Loyola University Chicago, Graduate School of Nursing; Acute Care Nurse Practitioner, Loyola University Medical Center, Department of Anesthesiology and Perioperative Medicine, Maywood, IL
×
407 - Acute/Urgent/Emergency Care: OSA and Obesity Hypoventilation Syndrome in the ICU and Beyond: Are We Sleepwalking into Disaster?
CE Credit: 1.5; Rx Credit: 0.5
This is a session that will review the APRN’s role in identifying risk factors and clinical features for OSA or hypoventilation in their patients. Included will be the most current evidence-based guidelines for screening and intervention in this population. There will be a comprehensive review of the pathophysiological risk these disease states place on the patients under their care.
Learning Outcomes/Objectives:
Describe the anatomical and physiological features that place a patient at risk for OSA or OHS.
Identify the current evidence-based guidelines for screening and interventions.
Discuss the significant pathophysiological risk for patients with untreated OSA and/or OHS.
